Strategic partnership with Lunit

Artificial intelligence meets clinical image data expertise: That is at the core of our strategic partnership with Lunit, a global leader in AI-based cancer diagnostics.

At the Ruhr Radiology Congress 2025 , users of our JiveX-Software were able to experience for the first time how they and their patients could benefit from the seamless integration of state-of-the-art AI diagnostic tools from Lunit into JiveX. The added value is immediately apparent:

• Seamless access to AI analyses – directly in your familiar JiveX workflow
• Greater diagnostic accuracy – through AI-supported real-time second opinions
• Time savings and increased efficiency – automatic pre-evaluation and prioritization of examinations
• Improved patient care – through faster, more accurate, and more consistent findings

AI solutions for the breast and lung

Since its founding in 2013, Lunit (short for “learning unit”) has developed a range of clinically proven solutions for various imaging procedures, including the Lunit INSIGHT Breast Suite for 2D (MMG – officially approved as an independent second reviewer in accordance with the MDR since the beginning of 2025) and 3D (DBT) mammography as well as Lunit INSIGHT CXR for the analysis of lung X-rays. In addition, the company, which originates from South Korea, offers RBfracture™ , an AI solution for detecting fractures on musculoskeletal X-ray images. 

Backed by over 150 publications in leading journals such as JAMA Oncology, The Lancet Digital Health and Radiology, Lunit's technology enables earlier detection and empowers radiologists to achieve the highest diagnostic accuracy. Overall, Lunit solutions are utilized at over 7,000 locations worldwide.

저희 네트워크에 오신 것을 진심으로 환영합니다!*

*Welcome to our network!

We are pleased to announce a new strategic partnership: VISUS and Lunit  are pooling their expertise to provide radiologists with even better support for diagnosis and decision-making in the future.

Lunit is a global leader in AI-powered cancer diagnostics, with its mission being to “defeat cancer through AI.” The company offers clinically proven solutions for various imaging procedures, including Lunit INSIGHT Breast Suite for 2D (MMG – officially approved as an independent second reviewer in accordance with the MDR since early 2025) and 3D (DBT) mammography, as well as Lunit INSIGHT CXR for the analysis of lung X-rays.

Lunit also offers RBfracture™, an AI solution for detecting fractures on musculoskeletal X-rays.

Backed by over 150 publications in leading journals such as JAMA Oncology, The Lancet Digital Health, and Radiology, Lunit's technology enables earlier detection and empowers radiologists to achieve the highest diagnostic accuracy.

The integration of this technology into the JiveX software creates a direct added value for radiology customers:

• Seamless access to AI analyses – directly in your familiar JiveX workflow,
• greater diagnostic accuracy – through AI-supported real time second opinions,
• time savings and increased efficiency – automatic pre-evaluation and prioritization of examinations,
• improved patient care – through faster, more accurate, and more consistent findings.

Together, VISUS and Lunit are creating an ecosystem that intelligently integrates leading state-of-the-art AI technology into clinical workflows - practice-oriented, interoperable, and with a focus on benefits for users and patients alike.

Take advantage of live on-site consultations and schedule appointments with our representatives.